2019

Venture Capital Investment Team Completes Regulatory Due Diligence for Investment in Company with FDA-Regulated Products

As counsel to a venture capital investment team, our firm completed regulatory due diligence and advised on a major investment in a privately held company developing FDA-regulated products.

The Faegre Drinker Biddle & Reath LLP website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Drinker Biddle & Reath LLP's cookies information for more details.